Experiences with
Cyclophosphamide1,139 public posts
Want to take advantage of all our features? Just log in!
or
Lupkinis plus MMF most effective in lupus nephritis; tacrolimus safest
Most studies compared the effectiveness of MMF versus intravenous (into the vein, IV) cyclophosphamide or IV cyclophosphamide versus tacrolimus. Two studies compared Lupkinis, given in combination with MMF, with MMF alone.
CLL survival times ARE improving, thanks to BTK and BCL-2 inhibitors
Those older chemoimmunotherapy treatments, typically Bendamustine + Rituximab (BR) or Fludarabine + Cyclophosphamide + Rituximab (FCR), selected for tougher to treat sub-clones, which they cause through inducing DNA damage that will hopefully trigger apoptosis [u]if[/u] the TP53 gene isn't mutated or
Avacopan (Tavneos®) is accepted for use within NHSScotland.
Full details posted here: https://www.scottishmedicines.org.uk/media/7938/avacopan-tavneos-final-oct-2023-for-website.pdf
Indication under review: In combination with a rituximab or cyclophosphamide regimen, for the treatment of adult patients with severe, active granulomatosis with polyangiitis (GPA
Transformation of Richter's Transformation Treatment to combination targeted therapy - tislelizumab +zanubrutinib (ASH 2023)
Richter's transformation" [/i]
[i]
[/i]
Here's the paper from German CLL study group authors at the University of Cologne
[i]https://www.nature.com/articles/s41591-023-02722-9[/i]
[i]
[/i]
*R-CHOP is a combination of;
R = Rituximab, an anti-CD20 monoclonal antibody, the 'R' in FCR, BR, VR, etc
C = Cyclophosphamide